This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Data availability
A deidentified data set is available by contacting the corresponding author.
References
Lozoff B, Georgieff MK. Iron deficiency and brain development. Semin Pediatr Neurol. 2006;13:158–65. https://doi.org/10.1016/j.spen.2006.08.004.
Widdowson EM, Spray CM. Chemical development in utero. Arch Dis Child. 1951;26:205–14. https://doi.org/10.1136/adc.26.127.205.
Baker RD, Greer FR, Committee on Nutrition American Academy of Pediatrics. Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0–3 years of age). Pediatrics. 2010;126:1040–50. https://doi.org/10.1542/peds.2010-2576.
Gisslen T, Rao R, Georgieff MK. Anemia, iron supplementation, and the brain. Clin Perinatol. 2023;50:853–68.
Hayashibe H, Asayama K, Dobashi K, Kato K. Prenatal development of antioxidant enzymes in rat lung, kidney, and heart: marked increase in immunoreactive superoxide dismutases, glutathione peroxidase, and catalase in the kidney. Pediatr Res. 1990;27:472–5.
Cohen J, Khudanyan A, Lu J, Wing J, Olson S, Deloughery T, et al. A multicenter study evaluating the effectiveness and safety of single-dose low molecular weight iron dextran vs single-dose ferumoxytol for the treatment of iron deficiency. Am J Hematol. 2020;95:1572–7.
Brugnara C, Schiller B, Moran J. Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states. Clin Lab Haematol. 2006;28:303–8. https://doi.org/10.1111/j.1365-2257.2006.00812.x.
Ohls RK, Schibler KR, Tan S, Lowe JR, Beauman SS, Grisby CA, et al. Darbepoetin (Darbe) trial to improve red cell mass and neuroprotection in preterm infants. In: Oral Platform. Pediatric Academic Societies Meeting, Washington DC, Pediatric Academic Societies, The Woodlands, TX, U.S.A., E-PAS2023: 2150.4. 2023.
Acknowledgements
The authors thank Dr. Scott Snyder of Boise, ID, for providing the curated list of level III NICUs from which the sample was obtained free-of-charge.
Author information
Authors and Affiliations
Contributions
JJT, TMB: conception and design, collection and assembly of data, data analysis and interpretation, manuscript writing, editing, and final approval of manuscript. SMT, RDC, RKO: conception and design, manuscript writing, data analysis and interpretation, editing, and final approval of manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Tuttle, J.J., Bahr, T.M., Tweddell, S.M. et al. A survey of iron supplementation, iron status surveillance, and erythropoiesis stimulating agent use in level III NICUs in the United States. J Perinatol (2024). https://doi.org/10.1038/s41372-024-01950-2
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41372-024-01950-2